336 related articles for article (PubMed ID: 20006130)
1. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data.
Sørensen R; Hansen ML; Abildstrom SZ; Hvelplund A; Andersson C; Jørgensen C; Madsen JK; Hansen PR; Køber L; Torp-Pedersen C; Gislason GH
Lancet; 2009 Dec; 374(9706):1967-74. PubMed ID: 20006130
[TBL] [Abstract][Full Text] [Related]
2. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study.
Lamberts M; Olesen JB; Ruwald MH; Hansen CM; Karasoy D; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH; Hansen ML
Circulation; 2012 Sep; 126(10):1185-93. PubMed ID: 22869839
[TBL] [Abstract][Full Text] [Related]
3. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
[TBL] [Abstract][Full Text] [Related]
4. Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups.
Juul N; Gislason G; Olesen JB; Lamberts M; Hansen ML; Karasoy D; Christiansen CB; Torp-Pedersen C; Sorensen R
Eur Heart J Acute Cardiovasc Care; 2017 Sep; 6(6):511-521. PubMed ID: 24936092
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic treatment and major adverse cardiac events after bleeding in patients with myocardial infarction: a retrospective analysis of nationwide registry data.
Nabi H; Rørth R; Tajchman DH; Holmvang L; Torp-Pedersen C; Gislason G; Fosbøl EL; Køber L; Sørensen R
Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):14-21. PubMed ID: 31274145
[TBL] [Abstract][Full Text] [Related]
6. Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
; Connolly SJ; Pogue J; Hart RG; Hohnloser SH; Pfeffer M; Chrolavicius S; Yusuf S
N Engl J Med; 2009 May; 360(20):2066-78. PubMed ID: 19336502
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study.
Jackson LR; Ju C; Zettler M; Messenger JC; Cohen DJ; Stone GW; Baker BA; Effron M; Peterson ED; Wang TY
JACC Cardiovasc Interv; 2015 Dec; 8(14):1880-9. PubMed ID: 26718518
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction.
Sørensen R; Abildstrøm SZ; Hansen PR; Hvelplund A; Andersson C; Charlot M; Fosbøl EL; Køber L; Madsen JK; Gislason GH; Torp-Pedersen C
J Am Coll Cardiol; 2011 Mar; 57(10):1202-9. PubMed ID: 21371637
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial.
Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Mark B; Zahn R; Senges J; Gottwik M
Thromb Haemost; 2008 Jan; 99(1):155-60. PubMed ID: 18217148
[TBL] [Abstract][Full Text] [Related]
10. Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable.
Connolly SJ; Eikelboom JW; Ng J; Hirsh J; Yusuf S; Pogue J; de Caterina R; Hohnloser S; Hart RG;
Ann Intern Med; 2011 Nov; 155(9):579-86. PubMed ID: 22041946
[TBL] [Abstract][Full Text] [Related]
11. Adherence to guidelines for the prescribing of double and triple combinations of antithrombotic agents.
Warlé-Van Herwaarden MF; Roukens M; Pop GA; Lamfers EJ; De Smet PA; Kramers C
Eur J Prev Cardiol; 2014 Feb; 21(2):231-43. PubMed ID: 22684153
[TBL] [Abstract][Full Text] [Related]
12. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
[TBL] [Abstract][Full Text] [Related]
13. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Labos C; Dasgupta K; Nedjar H; Turecki G; Rahme E
CMAJ; 2011 Nov; 183(16):1835-43. PubMed ID: 21948719
[TBL] [Abstract][Full Text] [Related]
14. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.
Stuckey TD; Kirtane AJ; Brodie BR; Witzenbichler B; Litherland C; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Mehran R; Généreux P; Ben-Yehuda O; Simonton CA; Stone GW;
JACC Cardiovasc Interv; 2017 Aug; 10(16):1607-1617. PubMed ID: 28780034
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
[TBL] [Abstract][Full Text] [Related]
16. Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction.
Fosbol EL; Wang TY; Li S; Piccini JP; Lopes RD; Shah B; Mills RM; Klaskala W; Alexander KP; Thomas L; Roe MT; Peterson ED
Am Heart J; 2012 Apr; 163(4):720-8. PubMed ID: 22520540
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic drugs and subarachnoid haemorrhage risk. A nationwide case-control study in Denmark.
Pottegård A; García Rodríguez LA; Poulsen FR; Hallas J; Gaist D
Thromb Haemost; 2015 Nov; 114(5):1064-75. PubMed ID: 26202836
[TBL] [Abstract][Full Text] [Related]
18. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M
JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657
[TBL] [Abstract][Full Text] [Related]
19. A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: clopidogrel plus aspirin versus aspirin alone.
Schleinitz MD; Heidenreich PA
Ann Intern Med; 2005 Feb; 142(4):251-9. PubMed ID: 15710958
[TBL] [Abstract][Full Text] [Related]
20. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
Bhatt DL; Fox KA; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Flather MD; Haffner SM; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Brennan DM; Fabry-Ribaudo L; Booth J; Topol EJ;
N Engl J Med; 2006 Apr; 354(16):1706-17. PubMed ID: 16531616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]